X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73) 73
Book Review (8) 8
Patent (7) 7
Publication (7) 7
Conference Proceeding (4) 4
Book Chapter (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45) 45
humans (42) 42
male (30) 30
adult (25) 25
middle aged (25) 25
female (24) 24
aged (21) 21
oncology (19) 19
prognosis (16) 16
cancer (15) 15
aged, 80 and over (13) 13
metastasis (12) 12
pathology (11) 11
immunohistochemistry (9) 9
thymoma (9) 9
expression (8) 8
urology & nephrology (8) 8
thymus (7) 7
urology (7) 7
care and treatment (6) 6
cell line, tumor (6) 6
risk factors (6) 6
thymoma - pathology (6) 6
thymus neoplasms - pathology (6) 6
adolescent (5) 5
animals (5) 5
autoimmunity (5) 5
biopsy (5) 5
carcinoma (5) 5
lymphatic metastasis (5) 5
neoplasms (5) 5
patients (5) 5
polymerase chain reaction (5) 5
surgery (5) 5
survival (5) 5
treatment outcome (5) 5
tumors (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast-cancer (4) 4
cell biology (4) 4
chemotherapy (4) 4
classification (4) 4
development and progression (4) 4
down-regulation (4) 4
gene expression (4) 4
medicine & public health (4) 4
multivariate analysis (4) 4
neoplasm staging (4) 4
node metastasis (4) 4
prostate cancer (4) 4
radiology (4) 4
radiology and nuclear medicine (4) 4
radiology, nuclear medicine & medical imaging (4) 4
radiotherapy (4) 4
rectum (4) 4
research (4) 4
therapy (4) 4
abridged index medicus (3) 3
analysis (3) 3
antibodies, monoclonal, humanized (3) 3
apoptosis (3) 3
article (3) 3
bioindicators (3) 3
biomarkers, tumor - genetics (3) 3
biomarkers, tumor - metabolism (3) 3
bladder-cancer (3) 3
camptothecin - administration & dosage (3) 3
camptothecin - analogs & derivatives (3) 3
cancer patients (3) 3
cell-proliferation (3) 3
cetuximab (3) 3
chemoradiotherapy (3) 3
child (3) 3
cohort studies (3) 3
colorectal cancer (3) 3
combined therapy (3) 3
disease progression (3) 3
epithelial tumors (3) 3
gene-expression (3) 3
genes (3) 3
genetic aspects (3) 3
health aspects (3) 3
hematology, oncology and palliative medicine (3) 3
impact (3) 3
in situ hybridization, fluorescence (3) 3
in-situ hybridization (3) 3
irinotecan (3) 3
liver (3) 3
liver neoplasms - secondary (3) 3
lymphangiogenesis (3) 3
lymphatic vessels - pathology (3) 3
medicine (3) 3
messenger-rna (3) 3
metastases (3) 3
metastatic colorectal-cancer (3) 3
mutation (3) 3
myasthenia gravis (3) 3
myasthenia gravis - immunology (3) 3
myasthenia-gravis (3) 3
neoadjuvant therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. 1032 - 1038
Purpose Mutations in KRAS and BRAF genes as well as the loss of expression of phosphatase and tensin homolog (PTEN) (deleted on chromosome 10) are associated... 
Radiology | Hematology, Oncology and Palliative Medicine | PTEN | BRAF | KRAS | Cetuximab | Chemoradiotherapy | PLUS IRINOTECAN | PHASE-II | NEOADJUVANT THERAPY | MONOCLONAL-ANTIBODY | COMBINATION | METASTATIC COLORECTAL-CANCER | PATHOLOGICAL COMPLETE RESPONSE | ONCOLOGY | PREOPERATIVE CETUXIMAB | CHEMORADIATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Capecitabine | Humans | Middle Aged | Male | Neoplasm Staging - methods | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Rectal Neoplasms - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Camptothecin - administration & dosage | Female | Remission Induction - methods | Camptothecin - analogs & derivatives | Genes, ras - genetics | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | PTEN Phosphohydrolase - metabolism | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Chemoradiotherapy, Adjuvant - methods | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Rectal Neoplasms - metabolism | Mutation | Deoxycytidine - analogs & derivatives | Care and treatment | Epidermal growth factor | Phosphatases | Gene mutations | Genes | Colorectal cancer | Genetic aspects | Metastasis | Cancer | Index Medicus | ANTIBODIES | PATIENTS | NEOPLASMS | RECTUM | BIOPSY | GENE MUTATIONS | METASTASES | RADIATION DOSES | CHROMOSOMES | GROWTH FACTORS | GENES | RADIOLOGY AND NUCLEAR MEDICINE | RECEPTORS | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 5, pp. 1487 - 1493
Purpose To evaluate the safety and efficacy of preoperative radiotherapy (RT) in combination with cetuximab, capecitabine, and irinotecan in patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | Irinotecan | Rectal cancer | Cetuximab | Capecitabine | Chemoradiotherapy | I/II | NEOADJUVANT THERAPY | ADJUVANT THERAPY | FLUOROURACIL | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | 5-FLUOROURACIL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Rectal Neoplasms - surgery | Deoxycytidine - administration & dosage | Lymphatic Metastasis | Combined Modality Therapy - adverse effects | Remission Induction | Rectal Neoplasms - radiotherapy | Proctitis - etiology | Nausea - etiology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vomiting - etiology | Diarrhea - etiology | Aged | Combined Modality Therapy - methods | Leukopenia - etiology | Deoxycytidine - analogs & derivatives | Clinical trials | Radiotherapy | Index Medicus | SURGERY | PATIENTS | VOMITING | DIARRHEA | NEOPLASMS | RECTUM | DEATH | RADIATION DOSES | TOXICITY | POLYMERASE CHAIN REACTION | PROCTITIS | LIVER | NAUSEA | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | SKIN | COMBINED THERAPY | AMINOTRANSFERASES
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2016, Volume 138, Issue 1, pp. 98 - 109
Journal Article
Virchows Archiv, ISSN 0945-6317, 09/2013, Volume 463, Issue 3, pp. 379 - 390
Journal Article
Forum, ISSN 0947-0255, 2/2017, Volume 32, Issue 1, pp. 32 - 36
Trotz aller technologischen Innovationen und der Einführung „objektiver“ Leitkriterien bleibt die pathohistologische Diagnostik bis auf Weiteres eine... 
Pathologist | Hematology | Pathologe | Second opinion | Gynecology | Diagnostic errors | Internal Medicine | Oncology | Zweitmeinung | Diagnosefehler | Qualitätssicherung | Quality assurance | Medicine & Public Health | Onkologie | Surgical Oncology
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 10/2016, Volume 51, Issue 10, pp. 971 - 984
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, pp. e65064 - e65064
Background: The identification of additional prognostic markers to improve risk stratification and to avoid overtreatment is one of the most urgent clinical... 
LUNG-CANCER | CELLS | OVEREXPRESSION | METASTASIS | MULTIDISCIPLINARY SCIENCES | IN-SITU HYBRIDIZATION | HMGA1 | RADICAL PROSTATECTOMY | GROUP PROTEIN I(Y) | MYC EXPRESSION | IDENTIFICATION | Multivariate Analysis | Prostatic Neoplasms - metabolism | Prognosis | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Transcriptome | Male | MicroRNAs - metabolism | Risk | Prostatic Neoplasms - genetics | RNA Interference | Treatment Failure | Biomarkers, Tumor - metabolism | Adult | 3' Untranslated Regions | Binding Sites | HMGA1a Protein - genetics | Neoplasm Recurrence, Local - metabolism | Prostatic Neoplasms - surgery | Down-Regulation | Kaplan-Meier Estimate | HMGA1a Protein - metabolism | Prostatic Neoplasms - mortality | Disease-Free Survival | Cell Line, Tumor | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Cohort Studies | Cancer patients | Care and treatment | DNA microarrays | MicroRNA | Gene expression | Health aspects | Prostate cancer | Risk factors | Pediatrics | Regulators | Correlation | Lung cancer | Metastasis | Cancer therapies | Urology | Clinical outcomes | Proteins | Bioindicators | Risk groups | MiRNA | Health risks | Risk analysis | Ribonucleic acid--RNA | Patients | Androgens | Overexpression | MicroRNAs | Stem cells | Biomarkers | Tumor suppressor genes | Thermal analysis | Prostate | Cancer | Index Medicus | RNA | Ribonucleic acid
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 3, pp. 810 - 816
Purpose To evaluate the toxicity and efficacy of preoperative intensity-modulated radiotherapy (IMRT) combined with temozolomide to improve local tumor control... 
Radiology | Hematology, Oncology and Palliative Medicine | Preoperative therapy | Temozolomide | IMRT | Radiotherapy | Soft-tissue sarcoma | ORAL SCHEDULE | POSTOPERATIVE RADIOTHERAPY | DOXORUBICIN | RADIATION-THERAPY | PHASE-II TRIAL | GLIOBLASTOMA | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | HIGH-RISK | EXTREMITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | BODY-WALL | Dacarbazine - adverse effects | Prospective Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Male | Radiotherapy, Intensity-Modulated - adverse effects | Dacarbazine - analogs & derivatives | Aged, 80 and over | Adult | Female | Postoperative Complications | Sarcoma - radiotherapy | Radiotherapy Dosage | Tumor Burden | Combined Modality Therapy - adverse effects | Sarcoma - drug therapy | Sarcoma - pathology | Remission Induction | Radiation Injuries - etiology | Antineoplastic Agents, Alkylating - therapeutic use | Nausea - etiology | Sarcoma - surgery | Vomiting - etiology | Aged | Combined Modality Therapy - methods | Antineoplastic Agents, Alkylating - adverse effects | Universities and colleges | Sarcoma | Alkylating agents | Radiation | Index Medicus | SURGERY | VOMITING | NEOPLASMS | ALKYLATING AGENTS | SYMPTOMS | MEDICINE | NUCLEAR MEDICINE | DISEASES | THERAPY | SARCOMAS | NAUSEA | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY
Journal Article